157 related articles for article (PubMed ID: 24969193)
1. Co-administration of ketoconazole and tacrolimus to kidney transplant recipients: cost minimization and potential metabolic benefits.
Elamin S; El-Magzoub AR; Dablouk N; Mahmoud F; Abbas M
Saudi J Kidney Dis Transpl; 2014 Jul; 25(4):814-8. PubMed ID: 24969193
[TBL] [Abstract][Full Text] [Related]
2. Co-administration of ketoconazole to tacrolimus-treated kidney transplant recipients: a prospective randomized study.
el-Dahshan KF; Bakr MA; Donia AF; Badr Ael-S; Sobh MA
Nephrol Dial Transplant; 2004 Jun; 19(6):1613-7. PubMed ID: 15034161
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of tacrolimus and ketoconazole in renal transplant recipients: cost analysis and review of metabolic effects.
Soltero L; Carbajal H; Rodríguez-Montalvo C; Valdés A
Transplant Proc; 2003 Jun; 35(4):1319-21. PubMed ID: 12826147
[TBL] [Abstract][Full Text] [Related]
4. Coadministration of ketoconazole and cyclosporine for kidney transplant recipients: long-term follow-up and study of metabolic consequences.
Sobh MA; Hamdy AF; El Agroudy AE; El Sayed K; El-Diasty T; Bakr MA; Ghoneim MA
Am J Kidney Dis; 2001 Mar; 37(3):510-7. PubMed ID: 11228175
[TBL] [Abstract][Full Text] [Related]
5. Ketoconazole-tacrolimus coadministration in kidney transplant recipients: two-year results of a prospective randomized study.
El-Dahshan KF; Bakr MA; Donia AF; Badr Ael-S; Sobh MA
Am J Nephrol; 2006; 26(3):293-8. PubMed ID: 16804292
[TBL] [Abstract][Full Text] [Related]
6. The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.
Orme ME; Jurewicz WA; Kumar N; McKechnie TL
Pharmacoeconomics; 2003; 21(17):1263-76. PubMed ID: 14986738
[TBL] [Abstract][Full Text] [Related]
7. Conversion From Once-Daily Prolonged-Release Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Liver Transplant Recipients.
Altieri M; Delaval G; Kimmoun E; Allaire M; Salamé E; Dumortier J
Exp Clin Transplant; 2018 Jun; 16(3):321-325. PubMed ID: 28697715
[TBL] [Abstract][Full Text] [Related]
8. Tacrolimus versus cyclosporin in renal transplantation in Italy: cost-minimisation and cost-effectiveness analyses.
Lazzaro C; McKechnie T; McKenna M
J Nephrol; 2002; 15(5):580-8. PubMed ID: 12455727
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system.
Spence MM; Nguyen LM; Hui RL; Chan J
Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134
[TBL] [Abstract][Full Text] [Related]
10. Tacrolimus reduction with everolimus addition for calcineurin inhibitor-induced arteriolopathy in kidney allografts.
Miura M; Higashiyama H; Fukasawa Y; Itoh Y; Tamaki T
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():58-60. PubMed ID: 26031588
[TBL] [Abstract][Full Text] [Related]
11. Nationwide conversion to generic tacrolimus in pediatric kidney transplant recipients.
Naicker D; Reed PW; Ronaldson J; Kara T; Wong W; Prestidge C
Pediatr Nephrol; 2017 Nov; 32(11):2125-2131. PubMed ID: 28660366
[TBL] [Abstract][Full Text] [Related]
12. A UK analysis of the cost of switching renal transplant patients from an immediate-release to a prolonged-release formulation of tacrolimus based on differences in trough concentration variability.
Muduma G; Odeyemi I; Pollock RF
J Med Econ; 2014 Jul; 17(7):520-6. PubMed ID: 24754700
[TBL] [Abstract][Full Text] [Related]
13. Dose-Response Relationship Between Diltiazem and Tacrolimus and Its Safety in Renal Transplant Recipients.
Choong CL; Wong HS; Lee FY; Lee CK; Kho JV; Lai YX; Vikneswaran T
Transplant Proc; 2018 Oct; 50(8):2515-2520. PubMed ID: 30316389
[TBL] [Abstract][Full Text] [Related]
14. Expected and Observed Glomerular Filtration Rates in Kidney Transplant Patients Converted to Once Daily Tacrolimus: 10 Years of Follow-up.
Tinti F; Schiaffini G; Umbro I; Zavatto A; Poli L; Pretagostini R; Garofalo M; Bachetoni A; Lai S; D'Alessandro MD; Mitterhofer AP
Transplant Proc; 2020 Jun; 52(5):1547-1551. PubMed ID: 32307145
[TBL] [Abstract][Full Text] [Related]
15. Clinically Significant Drug Interaction Between Clotrimazole and Tacrolimus in Pancreas Transplant Recipients and Associated Risk of Allograft Rejection.
Viesselmann CW; Descourouez JL; Jorgenson MR; Radke NA; Odorico JS
Pharmacotherapy; 2016 Mar; 36(3):335-41. PubMed ID: 26877191
[TBL] [Abstract][Full Text] [Related]
16. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction.
Shitrit D; Ollech JE; Ollech A; Bakal I; Saute M; Sahar G; Kramer MR
J Heart Lung Transplant; 2005 Dec; 24(12):2148-52. PubMed ID: 16364864
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation.
Glander P; Waiser J; Kasbohm S; Friedersdorff F; Peters R; Rudolph B; Wu K; Budde K; Liefeldt L
Clin Transplant; 2018 Aug; 32(8):e13311. PubMed ID: 29888809
[TBL] [Abstract][Full Text] [Related]
18. Clinical features of acute reversible tacrolimus (FK 506) nephrotoxicity in kidney transplant recipients.
Katari SR; Magnone M; Shapiro R; Jordan M; Scantlebury V; Vivas C; Gritsch A; McCauley J; Starzl T; Demetris AJ; Randhawa PS
Clin Transplant; 1997 Jun; 11(3):237-42. PubMed ID: 9193849
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of ketoconazole and tacrolimus therapy: a transplanted rat model.
Barakat N; Sabry A; El-Agroudy A; Hawas S; Abdel-Maboud M; El-Shair MA; Ghoneim MA
Int Urol Nephrol; 2005; 37(3):633-9. PubMed ID: 16307354
[TBL] [Abstract][Full Text] [Related]
20. Impact of Clotrimazole Fungal Prophylaxis on Tacrolimus Exposure in Kidney Transplant Recipients: A Retrospective Study.
El-Sayed A; Vidal J; Khanmoradi K; Knorr JP
Transplant Proc; 2021 Jun; 53(5):1583-1588. PubMed ID: 33962777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
